24-nation TB treatment survey released

Organisation: Position: Deadline Date: Location:

Stop TB Partnership and Médecins Sans Frontières (MSF) have released a joint publication, which surveys tuberculosis treatment (TB) and diagnosis policy and practice in 24 countries, reports Health-e News.

According to the report, about 70% of surveyed countries had no policies in place to ensure people who were thought to have TB or drug-resistant TB had access to rapid molecular testing early. The finding comes as on about a quarter of multidrug-resistant TB patients worldwide receive treatment, according to the World Health Organisation.

Meanwhile, the 92-page report says South Africa is at the forefront of Gene Xpert rapid TB testing implementation, having opted for replacing smear microscopy with the machine and achieving 100% coverage in the public sector.

The report recommends countries expand access to rapid molecular TB testing to ensure early diagnosis and treatment, while reducing transmission and the emergence of drug-resistant TB. It adds that this move will also reduce costs associated with TB diagnosis and treatment in the long run.

The report goes on to argue that if the world is to meet the Sustainable Development Goals target to End TB by 2030, aggressive efforts must start now to adopt and implement the key policies and practices, including: the removal or policies that mandate compulsory hospitalisation for TB patients, and have hospitalisation depend on clinical need; the proactive registration or new medicines in countries where clinical trials take place and other high-burden TB countries even in small markets; and the acceleration of combined drug research to create appropriate regimens.

Health-e News material

Receive Medical Brief's free weekly e-newsletter

Related Posts

Thank you for subscribing to MedicalBrief

MedicalBrief is Africa’s premier medical news and research weekly newsletter. MedicalBrief is published every Thursday and delivered free of charge by email to over 33 000 health professionals.

Please consider completing the form below. The information you supply is optional and will only be used to compile a demographic profile of our subscribers. Your personal details will never be shared with a third party.

Thank you for taking the time to complete the form.